Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

BloodStor biopreservation media product platform for cord blood banking industry

BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announced the launch of its BloodStor biopreservation media product platform.

31 Aug 2009

Ranaz Corporation to raise funds through private placement

Ranaz Corporation ("Ranaz") (TSXV: RNZ), a company specialized in the manufacturing and marketing of protein and dietary supplements, announces that it intends to raise $675,000 through a non-brokered private placement of units.

29 Aug 2009

Ranaz reports second quarter 2009 financial results

Ranaz Corporation ("Ranaz"), a company specialized in the manufacturing and marketing of protein and dietary supplements, reported its results today for the second quarter ended June 30, 2009.

29 Aug 2009

Covalon Technologies announces fiscal 2009 third-quarter results

Covalon Technologies Ltd. (TSX VENTURE:COV) announces the release of its financial statements for the third quarter of fiscal 2009 ending June 30, 2009. Revenues from product sales, coating services and licensing fees for the three months ended June 30, 2009 were $401,837, an increase of $64,575 over the same period in the previous year.

28 Aug 2009

Sinovac to supply its Anflu seasonal flu vaccine to the Beijing Public Health Bureau

Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the Beijing Public Health Bureau has selected Sinovac as one of the four manufacturers to supply Anflu(R), Sinovac's seasonal influenza vaccine, for the benefit of the citizens of Beijing. The Beijing Public Health Bureau completed the bidding process for the purchase of flu vaccines and corresponding services for 2009 on August 26, 2009. The agreement will be executed after the public notice period.

28 Aug 2009

Bavarian Nordic generates a revenue of DKK 33 million in the first half of 2009

In the first half of 2009 Bavarian Nordic generated revenue of DKK 33 million and recorded a loss before tax of DKK 188 million. As of 30 June 2009 the Group's net free liquidity was DKK 489 million.

28 Aug 2009

Kamada finalizes agreement for the distribution of its intravenous alpha-1 antitrypsin in the United States

Kamada (TASE:KMDA), a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has entered into an exclusive agreement with a large US specialty pharmaceutical distributor company for the distribution of its flagship product, intravenous alpha-1 antitrypsin (AAT-IV) in the United States.

28 Aug 2009

Copan Diagnostics to expand manufacturing operations at its Murrieta facility

Despite tough economic times, Copan is proud to announce the expansion of its US operations. Copan Diagnostics, Inc. is undertaking a new multimillion dollar investment project to bring plastic transfer pipet and additional medical device manufacturing operations to its facility in Murrieta, California.

28 Aug 2009

DURECT signs agreement with King Pharmaceuticals to supply two excipients for REMOXY

DURECT Corporation (Nasdaq: DRRX) today reported that it has signed an exclusive long term excipient supply agreement with respect to REMOXY(R) with King Pharmaceuticals, Inc. (NYSE: KG). This agreement stipulates the terms and conditions under which DURECT will supply to King, based on DURECT's manufacturing cost plus a specified percentage mark-up, two key excipients used in the manufacture of REMOXY.

27 Aug 2009

Geron provides additional comments on the recent clinical hold of Spinal Cord Injury IND

Geron Corporation today provided additional comments on the recent clinical hold on its Spinal Cord Injury IND.

27 Aug 2009

Affymetrix and Beckman Coulter forge alliance to provide optimized genomic research solutions

Affymetrix, Inc. (Nasdaq: AFFX) and Beckman Coulter, Inc. today announced that they have entered into an agreement to offer researchers co-developed products from the market leaders in microarrays and automated liquid handlers.

From Beckman Coulter Life Sciences - Automation and Genomics 27 Aug 2009

California Bioscience Business Roundtable event hosted at the Quadrus Conference Center

Today a group of national and California-based partners hosted the California Bioscience Business Roundtable (BBR) event at the Quadrus Conference Center in Menlo Park. The event also featured Sam Youngman, the White Correspondent for The Hill newspaper, who provided a reporter's front row perspective on the unfolding health reform debate in Washington, D.C.

27 Aug 2009

Stemedica unveils two of its latest scientific discoveries at the 2009 World Stem Cell Summit

Stemedica Cell Technologies , Inc., ("Stemedica"), a world leader in stem cell research and manufacturing (a licensed manufacturer of clinical grade biological products as licensed by the State of California Food and Drug Branch) continues to advance the stem cell industry with the presentation of two of its latest scientific discoveries at the 2009 World Stem Cell Summit.

27 Aug 2009

Fluidigm manufactures more than 250 million microscopic NanoFlex valves at its Singapore biochip factory

Fluidigm today announced that its Singapore biochip factory has manufactured and shipped more than 250 million microscopic NanoFlex™ valves. The 250 million valves built into Fluidigm’s integrated fluidic circuits (IFCs) would be equivalent to the number of valves required for all the conventional plumbing – both residential and commercial – in a metropolitan region the size of the San Francisco Bay Area.

27 Aug 2009

25% increase in quarterly cash dividend announced by Kewaunee Scientific Corporation

Kewaunee Scientific Corporation (Nasdaq: KEQU) announced today that its Board of Directors increased the Company's quarterly cash dividend by 25% to ten cents per outstanding share, up from eight cents per outstanding share, payable on September 22, 2009 to stockholders of record at the close of business on September 8, 2009.

27 Aug 2009

Bayer Cropscience to invest $25 million for enhancing operational safety at its Institute site

Bayer CropScience today announced an investment of $25 million for further enhancing operational safety at its Institute, W.Va. site. As part of these plans, the company will reduce methyl isocyanate (MIC) storage by 80 percent.

27 Aug 2009

Endocyte receives payment for the advancement of epothilone-folate anti-cancer agent

Endocyte, Inc., a cancer drug discovery and development company, today announced it has received a milestone payment from Bristol-Myers Squibb Company (NYSE: BMY). This payment was triggered by the commencement of a Phase II clinical trial for an epothilone-folate anti-cancer agent identified through the collaboration between Endocyte and Bristol-Myers Squibb scientists.

26 Aug 2009

Kimball Electronics’ focus on growth of medical business to strengthen with the addition of two new members

Kimball Electronics Group, a subsidiary of Kimball International, Inc., has added Katie Eggert and Anita Conlin to the Business Development Team focused on growth of the Company’s medical sector.

26 Aug 2009

USP and FEUM agrees to collaborate on the development of standards for medicines

Demonstrating a significant commitment to advancing the quality of medicines for patients on behalf of both countries, the U.S. Pharmacopeial (USP) Convention and the Permanent Commission of the Pharmacopeia of the United Mexican States (FEUM) today agreed to collaborate on the development of standards for medicines.

26 Aug 2009

Urologix announces fiscal 2009 fourth-quarter and full-year financial results

Urologix®, Inc. (NASDAQ:ULGX), a medical device company focused on developing, manufacturing and marketing Cooled ThermoTherapy™ systems, a durable and effective catheter based in-office alternative to drugs or surgery for patients suffering from benign prostatic hyperplasia (BPH), today reported financial results for the fourth quarter ended June 30, 2009 and for fiscal year 2009.

26 Aug 2009

Manufacturing News and Research

Further Reading

BloodStor biopreservation media product platform for cord blood banking industry

Ranaz Corporation to raise funds through private placement

Ranaz reports second quarter 2009 financial results

Covalon Technologies announces fiscal 2009 third-quarter results

Sinovac to supply its Anflu seasonal flu vaccine to the Beijing Public Health Bureau

Bavarian Nordic generates a revenue of DKK 33 million in the first half of 2009

Kamada finalizes agreement for the distribution of its intravenous alpha-1 antitrypsin in the United States

Copan Diagnostics to expand manufacturing operations at its Murrieta facility

DURECT signs agreement with King Pharmaceuticals to supply two excipients for REMOXY

Geron provides additional comments on the recent clinical hold of Spinal Cord Injury IND

Affymetrix and Beckman Coulter forge alliance to provide optimized genomic research solutions

California Bioscience Business Roundtable event hosted at the Quadrus Conference Center

Stemedica unveils two of its latest scientific discoveries at the 2009 World Stem Cell Summit

Fluidigm manufactures more than 250 million microscopic NanoFlex valves at its Singapore biochip factory

25% increase in quarterly cash dividend announced by Kewaunee Scientific Corporation

Bayer Cropscience to invest $25 million for enhancing operational safety at its Institute site

Endocyte receives payment for the advancement of epothilone-folate anti-cancer agent

Kimball Electronics’ focus on growth of medical business to strengthen with the addition of two new members

USP and FEUM agrees to collaborate on the development of standards for medicines

Urologix announces fiscal 2009 fourth-quarter and full-year financial results

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®